ePlus
PLUS
92.79
-1.37
-1.46%
ePlus
US · PLUS
#2648 by market cap
Listed 1970
92.79
-1.37
-1.46%
Live - 5344 symbols - heartbeat 18s ago
· 2026-10-07 19:54
After-hours
92.79
0.00%
- Market cap
- 2.42B
- P/E (TTM)i
- 20.26
- P/Bi
- 2.26
- EPSi
- 5.03
- Div yieldi
- 1.10%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on PLUS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.91, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +22.12% YoY
Margins
- Gross margin
- 25.22%
- Operating margin
- 6.80%
- Net margin
- 5.43%
Key ratios & quality
- PEG ratioi
- 5.66
- Altman Z-Scorei
- 4.91
PEG uses trailing P/E against the 3-year net income growth rate (3.58%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.59B | 1.57B | 1.82B | 2.07B | 2.18B | 2.00B | 2.44B |
| Gross profit | 330.39M | 391.19M | 393.55M | 460.98M | 517.52M | 511.74M | 512.12M | 616.08M |
| Selling & admin expenses | 237.08M | 279.18M | 271.26M | 297.12M | 333.52M | 355.56M | 386.68M | 423.39M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 81.48M | 97.85M | 108.34M | 149.22M | 170.30M | 135.24M | 99.69M | 166.15M |
| Pretax profit | 86.23M | 95.96M | 106.91M | 146.88M | 162.97M | 135.24M | 106.12M | 173.44M |
| Tax | 23.04M | 26.88M | 32.51M | 41.28M | 43.62M | 37.91M | 29.69M | 49.32M |
| Net profit | 63.19M | 69.08M | 74.40M | 105.60M | 119.36M | 117.98M | 104.58M | 132.64M |
| Basic EPS | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 5 |
| Diluted EPS | 2.33 | 2.57 | 2.77 | 3.93 | 4.48 | 4.41 | 3.93 | 5.03 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 477.92M | 642.78M | 608.83M | 614.77M | 581.63M | 649.11M |
| Gross profit | 132.87M | 153.68M | 162.12M | 158.65M | 147.09M | 151.33M |
| Selling & admin expenses | 100.61M | 103.67M | 106.48M | 108.70M | 103.27M | 106.62M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 24.76M | 42.94M | 48.84M | 43.47M | 37.64M | 38.83M |
| Pretax profit | 25.73M | 43.55M | 54.00M | 45.59M | 37.04M | 41.96M |
| Tax | 7.84M | 11.54M | 15.84M | 12.19M | 11.61M | 11.68M |
| Net profit | 21.79M | 42.58M | 34.86M | 35.05M | 25.03M | 30.28M |
| Basic EPS | 1 | 2 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.95 | 1.61 | 1.32 | 1.33 | 0.76 | 1.16 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 560.10M | 649.80M | 777.59M | 897.48M | 1.10B | 1.27B | 1.36B | 1.43B |
| Cash & ST investments | 79.82M | 86.23M | 129.56M | 155.38M | 103.09M | 253.02M | 389.38M | 410.77M |
| Inventory | 50.49M | 50.27M | 69.96M | 155.06M | 243.29M | 139.69M | 120.44M | 200.89M |
| Total assets | 786.20M | 909.11M | 1.08B | 1.17B | 1.41B | 1.65B | 1.88B | 1.80B |
| Total current liabilities | 328.85M | 386.64M | 459.36M | 460.04M | 561.33M | 656.99M | 799.13M | 638.14M |
| Short-term debt | 154.23M | 199.12M | 154.50M | 169.71M | 165.43M | 128.39M | 89.53M | 119.69M |
| Long-term debt | 10.50M | 5.87M | 18.32M | 9.90M | 9.52M | 12.90M | -- | -- |
| Total liabilities | 361,945,000.00 | 422,968,000.00 | 514,365,000.00 | 505,465,000.00 | 632,561,000.00 | 751,690,000.00 | 908,431,000.00 | 731,982,000.00 |
| Total equity | 424.25M | 486.15M | 562.41M | 660.74M | 782.27M | 901.78M | 970.66M | 1.07B |
| Retained earnings | 341.14M | 410.22M | 484.62M | 507.85M | 627.20M | 742.98M | 843.21M | 956.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.36B | 1.40B | 1.37B | 1.45B | 1.43B | 1.50B |
| Cash & ST investments | 389.38M | 480.18M | 402.16M | 326.29M | 410.77M | 448.85M |
| Inventory | 120.44M | 101.05M | 154.14M | 240.98M | 200.89M | 145.96M |
| Total assets | 1.88B | 1.80B | 1.77B | 1.83B | 1.80B | 1.87B |
| Total current liabilities | 799.13M | 687.75M | 628.12M | 682.09M | 638.14M | 704.29M |
| Short-term debt | 89.53M | 129.42M | 98.53M | 133.15M | 119.69M | 112.55M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 908,431,000.00 | 778,704,000.00 | 720,745,000.00 | 768,386,000.00 | 731,982,000.00 | 795,022,000.00 |
| Total equity | 970.66M | 1.02B | 1.05B | 1.06B | 1.07B | 1.07B |
| Retained earnings | 843.21M | 888.65M | 916.85M | 945.31M | 956.00M | 979.21M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 39.41M | -74.17M | 129.51M | -20.57M | -15.43M | 248.45M | 302.15M | -116.23M |
| Depreciation & amortization | 18.64M | 19.16M | 19.99M | 24.31M | 18.59M | 22.50M | 27.18M | 27.62M |
| Free cash flow | 27.78M | -81.18M | 117.99M | -43.75M | -24.81M | 240.79M | 296.87M | -120.66M |
| Dividends paid | -- | -- | -- | -- | -- | 0 | 0 | -19.66M |
| Stock buybacks / issuance | -18.75M | -14.43M | -6.95M | -13.61M | -7.22M | -6.83M | -43.30M | -27.02M |
| Ending cash balance | 79.82M | 86.23M | 129.56M | 155.38M | 103.09M | 253.02M | 389.38M | 410.77M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 160.95M | -98.97M | -34.78M | -87.44M | 104.95M | 76.48M |
| Depreciation & amortization | 7.84M | 7.41M | 7.11M | 6.67M | 6.42M | 6.16M |
| Free cash flow | 159.09M | -99.80M | -35.77M | -88.86M | 103.78M | 75.62M |
| Dividends paid | 0 | 0 | -6.59M | -6.54M | -6.53M | -7.07M |
| Stock buybacks / issuance | -13.48M | -1.55M | -4.05M | -15.11M | -6.31M | -23.63M |
| Ending cash balance | 389.38M | 480.18M | 402.16M | 326.29M | 410.77M | 448.85M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.86 | 15.18 | 14.19 | 17.27 | 16.54 | 13.75 | 11.49 | 12.96 |
| ROA %i | 8.18 | 8.15 | 7.49 | 9.42 | 9.25 | 7.55 | 6.10 | 7.20 |
| ROIC %i | 11.48 | 11.01 | 10.50 | 13.50 | 13.62 | 11.85 | 10.20 | 11.62 |
| 5-year avg ROE %i | 15.63 | 15.31 | 15.16 | 15.57 | 15.81 | 15.44 | 14.64 | 14.40 |
| EBIT margin %i | 6.42 | 6.20 | 6.94 | 8.17 | 8.08 | 7.41 | 7.30 | 7.10 |
| FCF / sales %i | 2.02 | -- | 7.52 | -- | -- | 10.78 | 14.29 | -- |
| Current ratioi | 1.70 | 1.68 | 1.69 | 1.95 | 1.95 | 1.94 | 1.70 | 2.24 |
| Quick ratioi | 1.47 | 1.47 | 1.46 | 1.51 | 1.34 | 1.59 | 1.15 | 1.75 |
| Debt / assetsi | 20.95 | 23.46 | 16.05 | 15.40 | 12.37 | 8.55 | 4.76 | 6.65 |
| LT debt / equityi | 2.48 | 2.92 | 3.26 | 1.50 | 1.22 | 1.43 | -- | -- |
| Interest coveragei | 45.27 | 38.28 | 54.32 | 78.19 | 40.43 | 43.65 | 68.32 | -- |
| Revenue CAGR (3Y) %i | 4.46 | 6.05 | 3.40 | 9.88 | 9.19 | 11.57 | 3.18 | 5.71 |
| Net income CAGR (3Y) %i | 12.19 | 10.97 | 10.51 | 18.67 | 19.99 | 16.61 | -0.32 | 3.58 |
| FCF CAGR (3Y) %i | -- | -- | 16.21 | -- | -- | 26.84 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.49 | 12.18 | 12.23 | 13.11 | 12.96 | 11.50 |
| ROA %i | 6.10 | 6.86 | 7.03 | 7.38 | 7.20 | 6.56 |
| ROIC %i | 10.20 | 10.66 | 10.90 | 11.55 | 11.62 | 10.31 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.30 | 7.18 | 7.77 | 8.50 | 7.10 | 6.91 |
| FCF / sales %i | 14.29 | 4.57 | 3.78 | -- | -- | 2.24 |
| Current ratioi | 1.70 | 2.04 | 2.19 | 2.13 | 2.24 | 2.13 |
| Quick ratioi | 1.15 | 1.77 | 1.79 | 1.57 | 1.75 | 1.75 |
| Debt / assetsi | 4.76 | 7.19 | 5.58 | 7.27 | 6.65 | 6.03 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 68.32 | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product is the largest reported line at 81.59% of revenue, across 4 reported segments.
- The next-largest line, Professional services, is a distant second at 10.49% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product81.59%
Professional services10.49%
Managed services7.90%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.